ARDENT HEALTH INC (ARDT) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:ARDT - US03980N1072 - Common Stock
8.6 USD
-0.3 (-3.37%)
8.6 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.13B 5.32% | 5.409B 5.45% | 5.966B 10.29% | 6.478B 8.58% | 6.787B 4.77% | 7.171B 5.66% | 7.862B 9.64% | |
| EBITDA YoY % growth | 338.426M -23.15% | 356.685M 5.40% | 552.05M 54.77% | 552.67M 0.11% | 545.12M -1.37% | 586.91M 7.67% | N/A | |
| EBIT YoY % growth | 200.253M -33.95% | 215.843M 7.79% | 405.762M 87.99% | 345.03M -14.97% | 413.73M 19.91% | 438.84M 6.07% | N/A | |
| Operating Margin | 3.90% | 3.99% | 6.80% | 5.33% | 6.10% | 6.12% | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | 0.98 -19.91% | 1.42 44.62% | 1.55 8.68% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.32 -60.46% | 0.24 -17.15% | 0.42 -20.01% | 0.30 -42.02% | 0.48 48.32% | 0.31 28.77% | 0.46 11.17% | 0.31 2.63% | 0.51 7.36% |
| Revenue Q2Q % growth | 1.664B 3.59% | 1.623B 8.40% | 1.712B 4.06% | 1.682B 6.68% | 1.779B 6.91% | 1.721B 6.04% | 1.818B 6.19% | 1.764B 4.88% | 1.878B 5.56% |
| EBITDA Q2Q % growth | 133.88M -55.94% | 112.47M 8.89% | 147.19M -30.83% | 126.05M -3.87% | 163.33M 22.00% | 127.78M 13.61% | 154.49M 4.96% | 126.77M 0.57% | 172.75M 5.77% |
| EBIT Q2Q % growth | 99.971M -36.56% | 79.286M 18.18% | 115.81M -15.64% | 94.731M 475.59% | 134.36M 34.40% | 92.958M 17.24% | 116.95M 0.98% | 84.737M -10.55% | 125.76M -6.40% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.52 205.88% | 0.42 | 0.10 | 24.85% |
| Q2 2025 Q2Q % growth | 0.52 52.94% | 0.30 | 0.22 | 71.20% |
| Q1 2025 Q2Q % growth | 0.29 | 0.20 | 0.09 | 43.05% |
| Q4 2024 Q2Q % growth | 0.81 | 0.46 | 0.35 | 76.20% |
| Q3 2024 Q2Q % growth | 0.17 | 0.31 | -0.14 | -44.28% |
| Q2 2024 Q2Q % growth | 0.34 | 0.31 | 0.03 | 10.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.577B 8.75% | 1.578B | -1.254M | -0.08% |
| Q2 2025 Q2Q % growth | 1.645B 11.85% | 1.577B | 68.28M | 4.33% |
| Q1 2025 Q2Q % growth | 1.497B 4.04% | 1.528B | -30.766M | -2.01% |
| Q4 2024 Q2Q % growth | 1.606B | 1.514B | 92.289M | 6.10% |
| Q3 2024 Q2Q % growth | 1.45B | 1.481B | -31.183M | -2.11% |
| Q2 2024 Q2Q % growth | 1.471B | 1.487B | -16.08M | -1.08% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -50.73% | -11.11% | -47.58% |
| Revenue | 0% | -1.54% | 0.12% | 0.08% |